CCND1 and endometrial cancer: Two cases demonstrated mutation at amino acid P287 (P287S and P287T), while a third case contained a 12-bp in-frame deletion that eliminated amino acids 289–292, all of which resulted in cyclin D1 nuclear expression in more than 50% of endometrial cancer cells [10].